Detailed Report on Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

Complete report available @ Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope

- Extensive coverage of the Lung Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

A&G Pharmaceutical Inc Abbott Diagnostics Abcodia Ltd Aberystwyth University Acobiom Advanced Marker Discovery SL Advpharma Inc AIT Austrian Institute of Technology GmbH Almac Diagnostics Ltd Armune BioScience, Inc. Aurelium BioPharma Inc. Avant Diagnostics, Inc. BioAffinity Technologies, Inc. Biocept Inc BioChain Institute Inc Biodesix Inc BioMark Diagnostics Inc. BioMarker Strategies LLC BioNTech AG BioSystems International BioTime Inc Cangen Biotechnologies Inc Cellanyx Diagnostics, Inc. CellMax Life CeMines, Inc. Cepheid Ceres Nanosciences Inc Cernostics Inc. ChemImage Corporation Children's Hospital Boston Clarient Inc Courtagen Life Sciences Inc DiagnoCure Inc. EDP Biotech Corporation Emory University Epigenomics AG Eventus Diagnostics Inc Exact Sciences Corp Exiqon A/S Exosomics Siena SpA Fahy Gurteen UK Ltd Fina Biotech Fluxion Biosciences, Inc. Forschungszentrum Borstel French National Institute of Health and Medical Research Gene Express, Inc. GeneCentric Diagnostics, Inc. GenomicTree Inc Global Discovery Biosciences Corporation GlycoZym HalioDx SAS HTG Molecular Diagnostics Inc ImmunoCellular Therapeutics Ltd Inivata Ltd Insight Genetics Inc InterGenetics Inc IV Diagnostics, Inc. Janssen Biotech Inc Laboratorios SALVAT SA Louisville Bioscience, Inc. Mayo Clinic US MDNA Life Sciences Inc MDxHealth SA MEDITE Cancer Diagnostics Inc Memory Dx LLC Merrimack Pharmaceuticals Inc Metabolon Inc Metanomics Health GmbH MetaStat Inc Milagen, Inc. Nanocytomics LLC Nanopore Diagnostics, LLC NEOMICS Co Ltd Novel Bio-spectrum Technologies Inc Nuvera Biosciences Inc OncoCyte Corp Oncolome Diagnostics Inc Onconome, Inc. OncoStem Diagnostics Pvt. Ltd On-Q-ity, Inc. OPKO Health Inc Orion Genomics LLC OTraces Inc. Oxford Gene Technology Ltd PeriRx LLC PleX Diagnostics Precision Biologics Inc PreMD Inc Proplex Technologies Llc Proteome Sciences Plc Proteomika Provista Diagnostics Inc Quest Diagnostics Inc Roche Diagnostics International Ltd Rosetta Genomics Ltd Roswell Park Cancer Institute Savicell Diagnostic Ltd. Siemens Healthcare GmbH Sienna Cancer Diagnostics Ltd Simon Fraser University Sividon Diagnostics GmbH SomaLogic Inc Southern Illinois University Carbondale Syndax Pharmaceuticals Inc The Wistar Institute Todos Medical Transgene SA Trinity College Dublin Universal Diagnostics, S. L. University of California San Francisco University of Chicago University of Colorado University of South Florida University of Strathclyde US Biomarkers Inc Vanderbilt University Ventana Medical Systems Inc Vigilant Biosciences, Inc. Viomics Inc. VisionGate, Inc. Vitatex Inc. VolitionRX Ltd Weizmann Institute of Science XEPTAGEN SpA Zetiq Technologies Ltd

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###